Jason Litten Joins Genelux Corporation as Chief Medical Officer
OncoDaily GU · Lycoming Career and Technology Center, PA · 1 mo ago
HealthcareFull-time
We are pleased to announce the appointment of Jason Litten as Chief Medical Officer at Genelux Corporation.
About the role
Dr. Litten brings over 20 years of experience in oncology drug development, with a proven track record of advancing innovative therapies from early-stage research through late-stage trials. His leadership will be instrumental as we progress Olvi-Vec through pivotal milestones and continue our mission to deliver next-generation #immunotherapies for patients facing aggressive #cancers.
Qualifications
Not specified.
Benefits
Not specified.
Pay
Not specified.
Schedule
Not specified.